Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks
Journal of Viral Hepatitis, 07/17/2012
Manns MP et al. – Glycyrrhizin exhibited a significantly higher ALT reduction compared to placebo after 12 weeks of therapy and an improvement of necro–inflammation and fibrosis after 52–weeks treatment. Generally, glycyrrhizin treatment was well tolerated.